Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Systematic review with meta-analysis: association of vitamin D status with clinical outcomes in adult patients with inflammatory bowel disease

Publikation: Bidrag til tidsskriftReviewForskningpeer review

DOI

  1. Letter: suicide risk among adult inflammatory bowel disease patients. Authors' reply

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Editorial: suicide and IBD-a call to action. Authors' reply

    Publikation: Bidrag til tidsskriftLederForskningpeer review

  1. Managing vitamin D deficiency in inflammatory bowel disease

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  2. Metabonomics in Gastroenterology and Hepatology

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Fluorescence-based tracing of transplanted intestinal epithelial cells using confocal laser endomicroscopy

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Methotrexate for inflammatory bowel disease: time for reconsideration

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. Biosimilars for Management of Crohn Disease

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

BACKGROUND: Vitamin D deficiency is highly prevalent among patients with IBD, however, data on its association with clinical outcomes are conflicting.

AIM: To perform a systematic review and meta-analysis to explore the association of low vitamin D status with clinical outcomes in patients with IBD.

METHODS: We searched PubMed, Embase, Scopus and Web of Science from inception to February 2018 for observational studies evaluating the association of low 25(OH)D status on IBD disease activity, mucosal inflammation, clinical relapse and quality of life. Odds ratios (ORs) were pooled and analysed using a random effects model.

RESULTS: Twenty-seven studies were eligible for inclusion comprising 8316 IBD patients (3115 ulcerative colitis, 5201 Crohn's disease). Among IBD patients, low 25(OH)D status was associated with increased odds of disease activity (OR 1.53, 95% CI 1.32-1.77, I2 = 0%), mucosal inflammation (OR 1.25, 95% CI 1.06-1.47, I2 = 0%), low quality of life (QOL) scores (OR 1.30, 95% CI 1.06-1.60, I2 = 0%) and future clinical relapse (OR 1.23, 95% CI 1.03-1.47, I2 = 0%). In subgroup analysis, low vitamin D status was associated with Crohn's disease activity (OR 1.66, 95% CI 1.36-2.03, I2 = 0%), mucosal inflammation (OR 1.39, 95% CI 1.03-1.85, I2 = 0%), clinical relapse (OR 1.35, 95% CI 1.14-1.59, I2 = 0%), and low QOL scores (OR 1.25, 95% CI 1.04-1.50, I2 = 0%) and ulcerative colitis disease activity (OR 1.47, 95% CI 1.03-2.09, I2 = 0%) and clinical relapse (OR 1.20, 95% 1.01-1.43, I2 = 0%).

CONCLUSIONS: Low 25(OH)D status is a biomarker for disease activity and predictor of poor clinical outcomes in IBD patients.

OriginalsprogEngelsk
TidsskriftAlimentary Pharmacology and Therapeutics
Vol/bind50
Udgave nummer11-12
Sider (fra-til)1146-1158
Antal sider13
ISSN0269-2813
DOI
StatusUdgivet - dec. 2019

Bibliografisk note

© 2019 John Wiley & Sons Ltd.

ID: 59003104